Aytu Biopharma AYTU
NASDAQ AYTU
$2.09 -0.05 (-2.34%)
At close: Oct 1, 2026 · 4:00 PM EDT

Aytu Biopharma (AYTU) Other Non-Current Assets (2013 - 2026)

Updated

Aytu Biopharma (AYTU) recorded Other Non-Current Assets of $601,000 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 50.1% from $1.2 million a year earlier but up 8.1% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Starting with fiscal Q4 2013, Aytu Biopharma's Other Non-Current Assets history includes 49 quarters.

  • Annual Other Non-Current Assets has declined for three straight fiscal years, though with a five-year compound annual growth rate of 5.3% (FY2021 to FY2026).
  • Across earlier fiscal years, Other Non-Current Assets came in at $1.2 million in FY2025 (-44.9%), $2.19 million in FY2024 (-14.1%), $2.55 million in FY2023 (+232.2%) and $766,000 in FY2022 (+64.7%).
  • Quarterly Other Non-Current Assets has ranged from $457,000 in fiscal Q2 2022 to $2.55 million in fiscal Q4 2023 over the past five years.
  • On a year-over-year basis, Other Non-Current Assets has declined for five consecutive quarters, with growth averaging 1.9% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 369.2% in fiscal Q3 2022, against a decline of 97.1% in fiscal Q1 2022 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $556,000 (Q3 2026), $738,000 (Q2 2026) and $939,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Aytu Biopharma 23.25 Mn -92.42 Mn 10.41 Mn 601,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 601,000.00
Mar 31, 2026 556,000.00
Dec 31, 2025 738,000.00
Sep 30, 2025 939,000.00
Jun 30, 2025 1.20 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 1.52 Mn
Sep 30, 2024 1.97 Mn
Jun 30, 2024 2.19 Mn
Mar 31, 2024 889,000.00
Dec 31, 2023 907,000.00
Sep 30, 2023 772,000.00
Jun 30, 2023 2.55 Mn
Mar 31, 2023 892,000.00
Dec 31, 2022 821,000.00
Sep 30, 2022 829,000.00
Jun 30, 2022 766,000.00
Mar 31, 2022 774,000.00
Dec 31, 2021 457,000.00
Sep 30, 2021 465,000.00
API Access

Aytu Biopharma Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AYTU&period=max&api_key=YOUR_API_KEY